• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    33 Stocks Moving In Friday's Mid-Day Session

    1/28/22 12:07:02 PM ET
    $AAPL
    $ARDS
    $BAK
    $BTBD
    Computer Manufacturing
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAPL alert in real time by email

    Gainers

    • Imperial Petroleum Inc. (NASDAQ:IMPP) shares jumped 126% to $2.6219. Imperial Petroleum, last month, posted Q3 revenue of $4.1 million.
    • Yoshitsu Co., Ltd (NASDAQ:TKLF) shares climbed 24.6% to $3.1760 after dropping 22% on Thursday.
    • Indonesia Energy Corporation Limited (NYSE:INDO) shares gained 18.2% to $6.96 after jumping 110% on Thursday.
    • Knightscope, Inc. (NASDAQ:KSCP) climbed 16.4% to $6.88. The company, on Thursday, priced its IPO at $10 per share.
    • Provention Bio, Inc. (NASDAQ:PRVB) shares rose 15.3% to $3.92 after the company announced its intent to resubmit the teplizumab BLA for the delay of clinical type 1 diabetes in at-risk individuals following its Type B pre-BLA resubmission meeting with the FDA.
    • Park City Group, Inc. (NASDAQ:PCYG) surged 14.7% to $6.10.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) gained 14% to $4.0841.
    • Ciner Resources LP (NYSE:CINR) rose 13.9% to $18.57. Ciner Resources announced a quarterly distribution of $0.65 for the fourth quarter.
    • Insulet Corporation (NASDAQ:PODD) surged 11.9% to $218.01 after the company announced FDA clearance of its Omnipod 5 Automated Insulin Delivery System.
    • Vaccinex, Inc. (NASDAQ:VCNX) shares gained 11% to $1.0150 as the company announced private placement at $1.11 per share on Thursday.
    • Braskem S.A. (NYSE:BAK) rose 9.1% to $18.62.
    • New Concept Energy, Inc. (NYSE:GBR) rose 7.3% to $2.9494 after gaining over 6% on Thursday.
    • Everspin Technologies, Inc.. (NASDAQ:MRAM) rose 7% to $8.54 after dropping 5% on Thursday.
    • Spectrum Pharmaceuticals, Inc.. (NASDAQ:SPPI) rose 6.7% to $0.6703 after dropping around 34% on Thursday.
    • FGI Industries Ltd. (NASDAQ:FGI) rose 6.7% to $3.37 after declining over 15% on Thursday. The company recently priced its IPO at $6 per share.
    • Visa Inc. (NYSE:V) gained 6.1% to $218.63 after the company reported better-than-expected Q1 EPS and sales results.
    • Calliditas Therapeutics AB (NASDAQ:CALT) gained 6% to $19.87 after the company reported commercial availability and initial sales of TARPEYO™.
    • Apple Inc. (NASDAQ:AAPL) rose 3.6% to $164.90 after reporting upbeat quarterly results.

    Check out these penny stocks insiders are buying

    Losers

    • Williams Industrial Services Group Inc. (NYSE:WLMS) shares dipped 27.8% to $2.21 after the company issued weak sales forecast for FY22.
    • Qurate Retail, Inc. (NASDAQ:QRTEA) fell 24.4% to $5.82. Qurate Retail said it sees preliminary Q4 retail revenue down 8% to 9%.
    • Volcon, Inc. (NASDAQ:VLCN) tumbled 22.2% to $2.94. Volcon priced its underwritten public offering of 6.67 million shares of common stock at $3 per share.
    • Movano Inc. (NASDAQ:MOVE) dropped 17.4% to $2.18. Movano, on Thursday, announced three new US patents.
    • Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) fell 16.9% to $1.67. Aridis Pharmaceuticals recently announced it received funding to evaluate inhaled monoclonal antibodies to block influenza and SARS-CoV-2 transmission.
    • Edgewise Therapeutics, Inc. (NASDAQ:EWTX) tumbled 16% to $11.57.
    • DouYu International Holdings Limited (NASDAQ:DOYU) dropped 15.6% to $2.1250. DouYu International shares jumped 14% on Thursday after a Reuters report claimed the company will be taken private by Tencent.
    • Innovid Corp. (NYSE:CTV) fell 14.2% to $4.6350.
    • BT Brands, Inc. (NASDAQ:BTBD) shares fell 13.8% to $2.42.
    • CITIC Capital Acquisition Corp. (NYSE:CCAC) tumbled 12.1% to $7.84.
    • Cue Biopharma, Inc. (NASDAQ:CUE) dropped 11.7% to $7.05. Early data from a trial evaluating Cue Biopharma’s CUE-101 combined with Merck & Co’s Keytruda (pembrolizumab) demonstrated that two out of four patients in dose-escalation cohorts had partial responses.
    • Weave Communications, Inc. (NYSE:WEAV) shares declined 10.4% to $8.13.
    • Sidus Space, Inc. (NYSE:SIDU) fell 7% to $10.05 after surging more than 31% on Thursday.
    • Western Digital Corporation (NASDAQ:WDC) shares fell 6.6% to $50.30. Western Digital posted upbeat earnings and sales results for its second quarter, but issued a weak forecast. Western Digital named Wissam Jabre as its CFO.
    • V.F. Corporation (NYSE:VFC) dropped 6.6% to $62.91 following Q3 results.

    Also check out insider selling in big stocks

    Get the next $AAPL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAPL
    $ARDS
    $BAK
    $BTBD

    CompanyDatePrice TargetRatingAnalyst
    Visa Inc.
    $V
    2/3/2026$370.00Neutral → Outperform
    Daiwa Securities
    Apple Inc.
    $AAPL
    1/30/2026$315.00 → $325.00Overweight
    Analyst
    Apple Inc.
    $AAPL
    1/30/2026$230.00 → $239.00Underweight
    Barclays
    Apple Inc.
    $AAPL
    1/30/2026$250.00 → $267.00Neutral
    Rosenblatt
    Apple Inc.
    $AAPL
    1/30/2026$300.00 → $315.00Buy
    Monness Crespi & Hardt
    Apple Inc.
    $AAPL
    1/30/2026$300.00Hold → Buy
    Maxim Group
    Western Digital Corporation
    $WDC
    1/30/2026$200.00 → $325.00Buy
    TD Cowen
    V.F. Corporation
    $VFC
    1/29/2026$16.00 → $20.00Market Perform
    Telsey Advisory Group
    More analyst ratings

    $AAPL
    $ARDS
    $BAK
    $BTBD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Sarraf Pasha bought $99,747 worth of shares (323,857 units at $0.31) (SEC Form 4)

    4 - Cue Biopharma, Inc. (0001645460) (Issuer)

    1/2/26 4:00:03 PM ET
    $CUE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Stonesifer Timothy C. bought $299,884 worth of shares (962 units at $311.73), increasing direct ownership by 27% to 4,591 units (SEC Form 4)

    4 - INSULET CORP (0001145197) (Issuer)

    12/8/25 4:02:55 PM ET
    $PODD
    Medical/Dental Instruments
    Health Care

    Director Fox Jonathan C bought $199,403 worth of shares (10,700 units at $18.64), increasing direct ownership by 82% to 23,702 units (SEC Form 4)

    4 - Edgewise Therapeutics, Inc. (0001710072) (Issuer)

    11/13/25 6:04:59 PM ET
    $EWTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $ARDS
    $BAK
    $BTBD
    SEC Filings

    View All

    SEC Form 144 filed by Western Digital Corporation

    144 - WESTERN DIGITAL CORP (0000106040) (Subject)

    2/6/26 4:02:44 PM ET
    $WDC
    Electronic Components
    Technology

    SEC Form 424B5 filed by Indonesia Energy Corporation Limited

    424B5 - Indonesia Energy Corp Ltd (0001757840) (Filer)

    2/5/26 4:08:40 PM ET
    $INDO
    Oil & Gas Production
    Energy

    Amendment: SEC Form SCHEDULE 13G/A filed by Weave Communications Inc.

    SCHEDULE 13G/A - Weave Communications, Inc. (0001609151) (Subject)

    2/5/26 1:43:39 PM ET
    $WEAV
    Computer Software: Prepackaged Software
    Technology

    $AAPL
    $ARDS
    $BAK
    $BTBD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Weave to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

    Weave (NYSE:WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced it will release its financial results for the fourth quarter and full year 2025 after U.S. markets close on Thursday, February 19, 2026. Company management will host a live audio webcast at 4:30 p.m. ET to discuss Weave's financial results and provide a business update. The live audio webcast will be available on the Weave Investor Relations website at investors.getweave.com. A replay of the webcast will be available on the same website shortly after its completion. About Weave Weave is the leading all-in-one customer experience a

    2/5/26 5:00:00 PM ET
    $WEAV
    Computer Software: Prepackaged Software
    Technology

    Knightscope Retains Lake Street to Support Growth Through Acquisitions

    Knightscope, Inc. (NASDAQ:KSCP), a security technology company building the Nation's first Autonomous Security Force, today announced that it has retained Lake Street Capital Markets, a full-service investment bank, as its exclusive buy-side financial advisor to support the Company's growth strategy through acquisitions of complementary businesses, technologies, and capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205409078/en/ This engagement reflects Knightscope's ongoing efforts to strengthen its market position and accelerate growth through selective, disciplined acquisitions aligned with its long-term strateg

    2/5/26 9:00:00 AM ET
    $KSCP
    Telecommunications Equipment
    Telecommunications

    Edgewise Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026

    BOULDER, Colo., Feb. 5, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc., (NASDAQ:EWTX), a leading muscle disease biopharmaceutical company, today announced that Behrad Derakhshan, Ph.D., Chief Operating Officer, will present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Thursday, February 12, 2026 at 3:00 pm ET. The presentation will be webcast live; a link for the webcast can be found on the Edgewise Events & Presentations page and will be accessible for replay, for a limited time, following the conference. It is recommended that users connect to the live webcas

    2/5/26 8:00:00 AM ET
    $EWTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $ARDS
    $BAK
    $BTBD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Visa upgraded by Daiwa Securities with a new price target

    Daiwa Securities upgraded Visa from Neutral to Outperform and set a new price target of $370.00

    2/3/26 7:57:45 AM ET
    $V
    Real Estate

    Barclays reiterated coverage on Apple with a new price target

    Barclays reiterated coverage of Apple with a rating of Underweight and set a new price target of $239.00 from $230.00 previously

    1/30/26 8:00:23 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    Analyst reiterated coverage on Apple with a new price target

    Analyst reiterated coverage of Apple with a rating of Overweight and set a new price target of $325.00 from $315.00 previously

    1/30/26 8:00:23 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    $AAPL
    $ARDS
    $BAK
    $BTBD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 17, 2024 - FDA Roundup: September 17, 2024

    For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a

    9/17/24 2:34:22 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    September 12, 2024 - FDA Authorizes First Over-the-Counter Hearing Aid Software

    For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea

    9/12/24 10:58:17 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    FDA Approval for TZIELD issued to PROVENTION BIO INC

    Submission status for PROVENTION BIO INC's drug TZIELD (ORIG-1) with active ingredient TEPLIZUMAB-MZWV has changed to 'Approval' on 11/17/2022. Application Category: BLA, Application Number: 761183, Application Classification:

    11/21/22 12:03:06 AM ET
    $PRVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $ARDS
    $BAK
    $BTBD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Massengill Matthew E sold $9,616,466 worth of shares (36,926 units at $260.43) (SEC Form 4)

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    2/6/26 6:09:23 PM ET
    $WDC
    Electronic Components
    Technology

    Chief Legal Officer & Corp Sec Tregillis Cynthia L sold $1,833,922 worth of shares (6,780 units at $270.49), decreasing direct ownership by 5% to 136,538 units (SEC Form 4)

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    2/6/26 6:09:36 PM ET
    $WDC
    Electronic Components
    Technology

    President and CEO Aggarwal Sanjeev exercised 7,084 shares at a strike of $6.68, increasing direct ownership by 1% to 556,496 units (SEC Form 4)

    4 - EVERSPIN TECHNOLOGIES INC. (0001438423) (Issuer)

    2/6/26 4:10:12 PM ET
    $MRAM
    Semiconductors
    Technology

    $AAPL
    $ARDS
    $BAK
    $BTBD
    Leadership Updates

    Live Leadership Updates

    View All

    Sidus Space Appoints Aerospace Executive Kelle Wendling to Board of Directors

    Veteran Space and Defense Leader Brings Three Decades of Government Contracting, ISR, and Space Systems Expertise to Sidus Board CAPE CANAVERAL, Fla., Jan. 5, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced the appointment of accomplished aerospace and defense executive Kelle Wendling to its Board of Directors. Ms. Wendling brings more than three decades of executive leadership and government contracting experience across space systems, Intelligence, Surveillance and Reconnaissance (ISR), and Federal Aviation Administration (FAA) markets.

    1/5/26 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Visa Foundation Board Appoints Najada Kumbuli as President of Visa Foundation

    Visa (NYSE:V), a global leader in digital payments, today announced that Najada Kumbuli has been appointed President of Visa Foundation, effective immediately. With guidance from the Board, Kumbuli will be responsible for managing Visa Foundation's impact investing and grantmaking, and will also serve as Visa Inc.'s head of global philanthropy. Kumbuli has more than 15 years of experience in investment strategy, impact evaluation, and leadership of global philanthropic programs. Prior to Visa Foundation, she served as the Investment Director at Calvert Impact Capital, a global impact investment firm. Kumbuli succeeds Graham Macmillan, who served as Visa Foundation's president since 2019.

    12/11/25 10:30:00 AM ET
    $V
    Real Estate

    Apple announces executive transitions

    Jennifer Newstead to join Apple as senior vice president, will become general counsel in March 2026 Kate Adams to retire late next year Lisa Jackson to retire Apple® today announced that Jennifer Newstead will become Apple's general counsel on March 1, 2026, following a transition of duties from Kate Adams, who has served as Apple's general counsel since 2017. She will join Apple as senior vice president in January, reporting to CEO Tim Cook and serving on Apple's executive team. In addition, Lisa Jackson, vice president for Environment, Policy, and Social Initiatives, will retire in late January 2026. The Government Affairs organization will transition to Adams, who will oversee the te

    12/4/25 4:30:00 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    $AAPL
    $ARDS
    $BAK
    $BTBD
    Financials

    Live finance-specific insights

    View All

    Western Digital Accelerates Storage Innovation for AI Era

    Now Rebranded as WD, the Company Unveils 100TB+ HDD Roadmap, Performance- and Power-Optimized Hard Drive Breakthroughs, and an Intelligent Platform Solution Redefining Storage Economics and Time-to-Value for Customers Key Highlights: Accelerated high-capacity roadmap: New world's highest capacity 40TB1 UltraSMR ePMR HDD is in customer qualifications now; HAMR HDD capacities scaling to 100TB+ and continued HAMR qualification momentum with hyperscale customers; overlapping technology paths (ePMR and HAMR) give customers choice and flexibility for smooth transitions without disruption New performance drive technology: High Bandwidth Drive and Dual Pivot design technologies deliver 2x b

    2/3/26 4:35:00 PM ET
    $WDC
    Electronic Components
    Technology

    Western Digital Authorizes Additional $4.0 Billion of Share Repurchases

    Western Digital Corporation (NASDAQ:WDC) today announced that its Board of Directors has authorized an additional $4.0 billion for share repurchases by the company pursuant to its share purchase program. As of February 2, 2026, the company had approximately $484 million remaining under the prior share repurchase authorization. The additional repurchase authorization is effective immediately. Share repurchases may be made on the open market or in privately negotiated transactions and may be made pursuant to a Rule 10b5-1 plan. "The expanded $4.0 billion buyback authorization demonstrates our confidence in WD's future and commitment to shareholder value," said CEO Irving Tan. "Our capital a

    2/3/26 8:00:00 AM ET
    $WDC
    Electronic Components
    Technology

    Apple reports first quarter results

    All-time records for total company revenue and EPS iPhone and Services revenue reach new all-time highs Apple® today announced financial results for its fiscal 2026 first quarter ended December 27, 2025. The Company posted quarterly revenue of $143.8 billion, up 16 percent year over year. Diluted earnings per share was $2.84, up 19 percent year over year. "Today, Apple is proud to report a remarkable, record-breaking quarter, with revenue of $143.8 billion, up 16 percent from a year ago and well above our expectations," said Tim Cook, Apple's CEO. "iPhone had its best-ever quarter driven by unprecedented demand, with all-time records across every geographic segment, and Services also

    1/29/26 4:30:00 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    $AAPL
    $ARDS
    $BAK
    $BTBD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Weave Communications Inc.

    SC 13D/A - Weave Communications, Inc. (0001609151) (Subject)

    12/9/24 7:11:00 PM ET
    $WEAV
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Weave Communications Inc.

    SC 13D/A - Weave Communications, Inc. (0001609151) (Subject)

    11/27/24 4:31:49 PM ET
    $WEAV
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Vaccinex Inc.

    SC 13D/A - VACCINEX, INC. (0001205922) (Subject)

    11/18/24 4:15:28 PM ET
    $VCNX
    Biotechnology: Pharmaceutical Preparations
    Health Care